ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
When TRT Is Not Enough (ED, Libido, & More)
Hypertension medications and erectile dysfunction
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 180673" data-attributes="member: 13851"><p>[ATTACH=full]9919[/ATTACH]</p><p><strong><span style="color: rgb(184, 49, 47)">FIGURE 1</span> Management of erectile dysfunction patients with and without cardiovascular disease. Modified with permission from Vlachopoulos et al. [53]. <span style="color: rgb(184, 49, 47)">*Low-risk patients</span> include those with complete revascularization (e.g. via coronary artery bypass grafting, stenting, or angioplasty), patients with asymptomatic controlled hypertension, those with mild valvular disease, and patients with left ventricular dysfunction/heart failure (NYHA classes I and II) who achieved five metabolic equivalents of the task (METS) without ischemia on recent exercise testing. <span style="color: rgb(184, 49, 47)">**Indeterminate risk patients</span> include diabetic patients, those with mild or moderate stable angina pectoris, past myocardial infarction (2–8 weeks) without intervention awaiting exercise electrocardiography, congestive heart failure (NYHA class III), and noncardiac sequelae of atherosclerotic disease (e.g. peripheral artery disease and a history of stroke or transient ischemic attack); this patient with erectile dysfunction may require assessment for additional vascular disease using carotid intima-media thickness or ankle-brachial index and subsequent reclassification to low or high risk. <span style="color: rgb(184, 49, 47)">***High-risk patients </span>include those with unstable or refractory angina pectoris, uncontrolled hypertension, congestive heart failure (NYHA class IV), recent myocardial infarction without intervention (2 weeks), high-risk arrhythmia (exercise-induced ventricular tachycardia, implanted internal cardioverter defibrillator with frequent shocks, and poorly controlled atrial fibrillation), obstructive hypertrophic cardiomyopathy with severe symptoms, and moderate-to-severe valve disease, particularly aortic stenosis. Where appropriate CVD, cardiovascular disease; FRS, Framingham risk score; NYHA, New York Heart Association; PDE5i, phosphodiesterase type 5 inhibitors; RF, risk factor; Tth, testosterone therapy.</strong></p></blockquote><p></p>
[QUOTE="madman, post: 180673, member: 13851"] [ATTACH type="full"]9919[/ATTACH] [B][COLOR=rgb(184, 49, 47)]FIGURE 1[/COLOR] Management of erectile dysfunction patients with and without cardiovascular disease. Modified with permission from Vlachopoulos et al. [53]. [COLOR=rgb(184, 49, 47)]*Low-risk patients[/COLOR] include those with complete revascularization (e.g. via coronary artery bypass grafting, stenting, or angioplasty), patients with asymptomatic controlled hypertension, those with mild valvular disease, and patients with left ventricular dysfunction/heart failure (NYHA classes I and II) who achieved five metabolic equivalents of the task (METS) without ischemia on recent exercise testing. [COLOR=rgb(184, 49, 47)]**Indeterminate risk patients[/COLOR] include diabetic patients, those with mild or moderate stable angina pectoris, past myocardial infarction (2–8 weeks) without intervention awaiting exercise electrocardiography, congestive heart failure (NYHA class III), and noncardiac sequelae of atherosclerotic disease (e.g. peripheral artery disease and a history of stroke or transient ischemic attack); this patient with erectile dysfunction may require assessment for additional vascular disease using carotid intima-media thickness or ankle-brachial index and subsequent reclassification to low or high risk. [COLOR=rgb(184, 49, 47)]***High-risk patients [/COLOR]include those with unstable or refractory angina pectoris, uncontrolled hypertension, congestive heart failure (NYHA class IV), recent myocardial infarction without intervention (2 weeks), high-risk arrhythmia (exercise-induced ventricular tachycardia, implanted internal cardioverter defibrillator with frequent shocks, and poorly controlled atrial fibrillation), obstructive hypertrophic cardiomyopathy with severe symptoms, and moderate-to-severe valve disease, particularly aortic stenosis. Where appropriate CVD, cardiovascular disease; FRS, Framingham risk score; NYHA, New York Heart Association; PDE5i, phosphodiesterase type 5 inhibitors; RF, risk factor; Tth, testosterone therapy.[/B] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
X (Twitter)
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
When TRT Is Not Enough (ED, Libido, & More)
Hypertension medications and erectile dysfunction
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top